E-commerce giant Amazon has now confirmed that 10 employees at its Coventry, UK warehouse contracted tuberculosis (TB) in ...

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...

Detecting latent tuberculosis infection (LTBI) is important, especially in high-risk populations including healthcare workers (HCWs). QuantiFERON-TB Gold Plus (QFT-Plus) is a new version of the ...

QuantiFERON grew 11% CER supported by solid gains in the Americas but also in EMEA as we maintain momentum in driving conversion of latent TB testing for the traditional skin test. Let us remember ...

The authors have declared no conflicts of interest. Background: Latent tuberculosis testing prior to immunosuppression is recommended by national and international guidelines. However, no structured ...

Objective To determine the cost-effectiveness of the QuantiFERON (QFT) test versus the tuberculin skin test (TST) in diagnosing latent tuberculosis infection (LTBI) in immunocompetent children under ...

Rates of sustained QuantiFERON-TB (QFT) test conversion did not differ significantly between Bacille Calmette-Guérin (BCG) revaccination and placebo. Alexander C. Schmidt, M.D., from the Gates Medical ...

QGEN has a relatively well-diversified portfolio across four segments on Sample Technologies, PCR/NA Amplification, Genomics/NGS, and Diagnostic Solutions. Their QIAstat-Dx’s multiplex syndromic ...

Bacille Calmette-Guérin revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection, defined by sustained QuantiFERON-TB test conversion. HealthDay News — Bacille ...

Is the Turing test still relevant in today's AI landscape? The advent of large language models has challenged its importance. When you purchase through links on our site, we may earn an affiliate ...

Bacille Calmette-Guérin (BCG) revaccination didn't help prevent sustained Mycobacterium tuberculosis infection in initially uninfected adolescents without HIV in a randomized trial from South Africa.